The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

Researchers conducted the QWINT-1 and QWINT-2 clinical trials to assess glycemic and patient-reported outcomes among those using once-weekly insulin efsitora.

No significantly increased risks observed for autoimmune disorder, atopic or allergic disorder, neurodevelopmental disorder.

Researchers compared radiologist performance and visual search patterns when reading screening mammograms with and without an AI decision support system.

This study examined the correlation between atopic dermatitis and the risk for chronic kidney disease using data from a Taiwanese health database.

To address the gap in sepsis management bundle compliance at a community hospital in Cleveland, Ohio, the authors created an intervention targeting patients who presented with sepsis upon admission, ...